Outcome of primary-breast-cancer patients with micrometastases: A long-term follow-up study

Lancet

Volumn 354, Issue 9174, 1999, Pages 197-202

  Mansi, Janine L ^a   Gogas, Helen ^a   Bliss, Judith M ^b   Gazet, Jean Claude ^a   Berger, Uta ^a   Coombes, R Charles ^c  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; EPITHELIAL MEMBRANE ANTIGEN;

ADULT; AGED; ARTICLE; ASPIRATION; BONE MARROW METASTASIS; BREAST CANCER; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STATISTICS; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; VASCULAR DISEASE;

EID: 0033578276     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)10175-7     Document Type: Article

References (26)

1. Dearnaley D.P., Sloane J.P., Ormerod M.G.et al. Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer. 44:1981;85-90.
2. Dearnaley D.P., Ormerod M.G., Sloane J.P.et al. Detection of isolated mammary carcinoma cells in marrow of patients with primary breast cancer. J R Soc Med. 76:1983;359-364.
3. Redding W.H., Coombes R.C., Monaghan P.et al. Detection of micrometastases in patients with primary breast cancer. Lancet. ii:1983;1271-1273.
4. Porro G., Ménard S., Tagliabue E.et al. Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients. Cancer. 61:1988;2407-2411.
5. Thor A., Viglione M.J., Ohuchi N.et al. Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrow. Breast Cancer Res Treat. 11:1988;133-145.
6. Cote R.J., Rosen P.P., Hakes T.B.et al. Monoclonal antibodies detect occult breast carcinoma metastases in bone marrow of patients with early stage disease. Am J Surg Pathol. 12:1988;333-340.
7. Ellis G., Ferguson M., Yamanaka E., Livingston R.B., Gown A.M. Monoclonal antibodies for the detection of occult carcinoma cells in bone marrow of breast cancer patients. Cancer. 63:1989;2509-2514.
8. Mansi J.L., Berger U., Easton D.et al. Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. BMJ. 295:1987;1093-1096.
9. Berger U., Bettelheim R., Mansi J.L., Easton D., Coombes R.C., Neville A.M. The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol. 90:1988;1-6.
10. Harbeck N., Untch M., Eierman W. Detection of tumour cells in the bone marrow at primary therapy: a new prognostic criterion in breast cancer? J Cancer Res Clin Oncol. 116(I)):1990;49. (abstr).
11. Cote R.J., Rosen P.P., Old L.J., Osborne M.P. Detection of bone marrow micrometastases in patients with early-stage breast cancer. Diagn Oncol. 1:1991;37-42.
12. Diel I.J., Kaufmann M., Goerner R., Costa S.D., Kaul S., Bastert G. Detection of tumour cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol. 10:1992;1534-1539.
13. Cote R.J., Rosen P.P., Lesser M.L., Old L.J., Osborne M.P. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol. 9:1991;1749-1756.
14. Mansi J.L., Easton D., Berger J.et al. Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years follow-up. Eur J Cancer. 27:1991;1552-1555.
15. Diel I.J., Kaufmann M., Costa S.D.et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst. 88:1996;1652-1658.
16. Harbeck N., Untch M., Pache L.et al. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer. 69:1994;566-571.
17. Diel I.J., Solomayer E.F., Costa S.D.et al. Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med. 339:1998;357-363.
18. Mansi J.L., Berger U., McDonnell T.et al. The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol. 7:1989;445-449.
19. Thomas P., Battifora H. Keratins versus epithelial membrane antigen in tumor diagnosis: an immunohistochemical comparison of five monoclonal antibodies. Hum Pathol. 18:1987;728-734.
20. Pinkus G.S., Kurtin P.J. Epithelial membrane antigen: a diagnostic discriminant in surgical pathology: immuno-histochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies. Hum Pathol. 16:1985;929-940.
21. Mansi J.L., Berger U., Wilson P., Shearer R., Coombes R.C. Detection of tumour cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J Urol. 139:1988;545-548.
22. Lindemann F., Schlimok G., Dirschedl P., Witte J., Riethmüller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet. 340:1992;685-689.
23. Sharp J.G., Kessinger A., Vaughan W.P.et al. Detection and clinical significance of minimal tumour contamination of peripheral blood stem cell harvests. Int J Cell Cloning. 10(1):1992;92-94.
24. Fields K.K., Elfenbein G.J., Trudeau W.L., Perkins J.B., Janssen W.E., Moscinski L.C. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol. 16:1996;1868-1876.
25. Passos-Coelho J., Ross A.A., Davis J.M.et al. Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide. Cancer Res. 54:1994;2366-2371.
26. Hermanek P. pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J Surg. 19:1995;184-190.